J Biol Chem, Vol. 274, Issue 35, 24625-24632, August 27, 1999
Differential Effects of Lipopolysaccharide and Tumor Necrosis
Factor on Monocytic I
B Kinase Signalsome Activation and I
B
Proteolysis*
Claudia
Fischer
,
Sharon
Page
,
Marion
Weber,
Tamara
Eisele,
Dieter
Neumeier, and
Korbinian
Brand§
From the Institute of Clinical Chemistry and Pathobiochemistry,
Klinikumrechts der Isar, Technical University Munich, Ismaninger
Strasse 22, 81675 Munich, Germany
 |
ABSTRACT |
The inflammatory mediators lipopolysaccharide
(LPS) and tumor necrosis factor (TNF) are potent activators of NF-
B.
This study compared the effect of these stimuli on endogenous I
B
kinase (IKK) signalsome activation and I
B
phosphorylation/proteolysis in human monocytic cells and investigated
the role of the signalsome proteins IKK-
, IKK-
, NF-
B-inducing
kinase (NIK), IKK-
(NF-
B essential modulator), and IKK
complex-associated protein. Kinase assays showed that TNF elicited a
rapid but short-lived induction of IKK activity with a 3-fold greater
effect on IKK-
than on IKK-
, peaking at 5 min. In contrast, LPS
predominantly stimulated IKK-
activity, which slowly increased,
peaking at 30 min. A second peak was observed at a later time point
following LPS stimulation, which consisted of both IKK-
and -
activity. The endogenous levels of the signalsome components were
unaffected by stimulation. Furthermore, our studies showed association
of the IKK-
/
heterodimer with NIK, I
B-
and -
in
unstimulated cells. Exposure to LPS or TNF led to differential patterns
of I
B-
and I
B-
disappearance from and reassembly with the
signalsome, whereas IKK-
, IKK-
, and NIK remained
complex-associated. NIK cannot phosphorylate I
B-
directly, but it
appears to be a functionally important subunit, because mutated NIK
inhibited stimulus-induced
B-dependent transcription
more effectively than mutated IKK-
or -
. Overexpression of IKK
complex-associated protein inhibited stimulus-mediated transcription,
whereas NF-
B essential modulator enhanced it. The understanding of
LPS- and TNF-induced signaling may allow the development of specific
strategies to treat sepsis-associated disease.
 |
INTRODUCTION |
Bacterial lipopolysaccharide
(LPS),1 a glycolipid membrane
component, accounts for many of the cellular responses to Gram-negative infections, including sepsis and the development of septic shock (1).
Once patients exhibit the septic shock syndrome and associated organ
failure, a high mortality rate of the affected individuals is observed
(1). The interaction of LPS with cells of, for example, the monocytic
lineage appears to be especially important because subsequent cellular
activation results in the release of highly active proinflammatory
molecules, such as tumor necrosis factor (TNF) and interleukin
(IL)-1
, which in turn mediate systemic effects (2, 3). One of the
key regulators of LPS-induced, as well as TNF- and IL-1
-induced,
gene expression at the interface between signal transduction and
transcription is the transcription factor NF-
B (4-6).
There is an ever-increasing body of evidence that suggests that
NF-
B/Rel plays an important role in gene regulation during inflammatory and immune reactions in a variety of disease settings (7-11). NF-
B regulatory sequences have been found in promoters or
enhancers of numerous genes, e.g. coding for the
proinflammatory cytokines TNF and IL-1
; the chemokines IL-8 and
monocyte chemotactic protein-1; several adhesion molecules, including
intercellular adhesion molecule-1 and vascular cell adhesion
molecule-1; and the procoagulatory protein tissue factor (5, 12-15).
The prototypic NF-
B dimer consists of the subunits p65 (RelA) and
p50, although other subunits, such as c-Rel, RelB, and p52 have been
identified (5). These dimeric NF-
B complexes are present in the
cytosol in an inactive state bound to inhibitory proteins, collectively termed I
B (5, 14, 15). Several I
B proteins have been identified,
including I
B-
(16, 17), I
B-
(18), and the more recently
cloned I
B-
(19). A variety of agents such as microbial pathogens
(for example, LPS), as well as inflammatory or lymphoproliferative
cytokines, including TNF and IL-1
, induce the activation of NF-
B
(5, 6, 14). This is mediated by a network of kinases leading to the
phosphorylation of I
B, which is subsequently degraded in an
ubiquitin-dependent step by the proteasome, a
multicatalytic high molecular weight protease system (16, 20-22). The
removal of the inhibitor I
B allows the translocation of the thus
activated NF-
B dimer into the nucleus.
The signaling mechanisms that lead to the phosphorylation of I
B, and
thereby NF-
B activation, are only partly understood and
characterized for TNF, IL-1
, and LPS (23-27). A high molecular weight I
B kinase (IKK) complex, also named the signalsome, has recently been identified, and it is postulated to represent a bona fide I
B kinase (28-32). Several kinase-active
components of this complex have been cloned, namely IKK-
, IKK-
,
and NF-
B-inducing kinase (NIK) (28-33). Furthermore, two adaptor or
scaffold proteins have been found, IKK-
/NF-
B essential modulator
(NEMO)/IKK-associated protein 1 (34-36) and IKK complex-associated
protein (IKAP) (37), which have been suggested to stabilize the high
molecular weight complex and/or regulate the kinase activity.
Additional kinases, such as mitogen-activated protein
kinase/extracellular-regulated kinase kinase kinase-1 (38) or
mitogen-activated ribosomal S6 protein kinase (pp90rsk)
(39), may assemble with the signalsome following activation of cells by
certain stimuli. For example, activation of NF-
B by TNF appears to
involve several upstream signaling proteins, including TRAF2 and RIP,
which in turn activate NIK, thereby initiating a signaling pathway that
results in I
B phosphorylation (23-25).
It should be mentioned that the functionality of these IKK signalsome
components has been mostly established under relatively unphysiological
overexpression conditions in easy to handle cell lines, such as HeLa,
293, or Chinese hamster ovary B (28-32). TNF and IL-1
were almost
exclusively used as activators of these systems (28-32), although LPS
has recently been reported to activate IKK (27). The regulation of
expression and activation of endogenous signalsome components in cell
types and conditions relevant for inflammation has not been
investigated in great detail. The present study was therefore designed
to compare the effect of TNF and LPS on endogenous IKK signalsome
activation and I
B phosphorylation/proteolysis in monocytic cells. In
addition, we investigated the involvement of IKK-
, IKK-
and NIK,
as well as the adaptor proteins IKK-
(NEMO) and IKAP, in these
signaling cascades.
 |
EXPERIMENTAL PROCEDURES |
Cell Culture Conditions and Reagents--
THP-1 human monocytic
cells (Deutsche Sammlung von Mikroorganismen und Zellkulturen,
Braunschweig, Germany) were maintained in suspension in RPMI 1640 (Glutamax-1, low endotoxin, Seromed, Berlin, Germany) containing 7%
fetal calf serum (Myoclone super plus, low endotoxin, BioWhittaker,
Walkersville, MD), 100 units/ml penicillin and 100 µg/ml streptomycin
(Life Technologies, Inc., Eggenstein, Germany) as described (40). For
the experiments, the cells were plated at a density of 3 × 106 cells/well in six-well culture dishes. Peripheral blood
mononuclear cells were isolated from blood samples of normal donors by
the Ficoll-Hypaque method as described (41). Monocytes were isolated from mononuclear cells by adherence to achieve a purity of
approximately 90% as determined by flow cytometry. The adherent
monocytes were cultured overnight in the same medium as THP-1 cells
with 10% fetal calf serum before the experiment was started. LPS
(Escherichia coli 0111:B4) and TNF were purchased from
Sigma. Endotoxin contamination was screened by the limulus amoebocyte
lysate assay (BioWhittaker), and only reagents with an endotoxin
content of <10 pg/ml were used in the experiments. A potential
toxicity of the cell culture conditions applied was monitored by cell
morphology and count, trypan blue dye exclusion, and the WST-1 cell
toxicity test (Roche Molecular Biochemicals, Mannheim, Germany).
Polyacrylamide Gel Electrophoresis and Western Blot
Analysis--
Cytosolic extracts were isolated as described earlier
(42). Electrophoresis was performed with 12.5% polyacrylamide gels (0.1% SDS) as described previously (40). The proteins were transferred to a nitrocellulose membrane using the wet blotting technique. After
transfer, the membranes were incubated with polyclonal antibodies against the carboxyl-terminal domains of the inhibitors I
B-
, -
(Santa Cruz Biotechnology, Heidelberg, Germany), and -
(a kind gift
from Prof. N. Rice, NCI-Frederick Cancer Research and Development
Center, National Institutes of Health, Frederick, MD), against the
kinases IKK-
, -
, or NIK (Santa Cruz Biotechnology), as well as
the scaffold protein IKK-
(using an antibody raised against the
mouse homologue of human IKK-
, namely NEMO, a gift from Prof. Alain
Israël and co-workers, Institut Pasteur, Paris, France), or with
a monoclonal antibody against
-actin (Sigma). In some experiments,
an antibody recognizing only the form of I
B-
phosphorylated at
Ser-32 was used (Calbiochem, Bad Soden, Germany). This incubation was
followed by the appropriate horseradish peroxidase-conjugated secondary
antibody (Dianova, Hamburg, Germany). The protein was visualized
on x-ray film using the Western blot chemiluminescent reagent plus (NEN
Life Science Products). The protein size was confirmed by molecular
weight standards (Amersham Pharmacia Biotech, Braunschweig, and
Bio-Rad).
Immunoprecipitation--
Cytosolic extracts were subjected to
immunoprecipitation (IP) (35, 43) in either TNT buffer (200 mM NaCl; 20 mM Tris-HCl, pH 7.5; 1% Triton
X-100; 1 mM dithiothreitol; 0.5 µM
4-(2-aminoethyl)-benzenesulfonyl fluoride; and 0.75 µg/ml each
leupeptin, antipain, aprotinin, pepstatin A, and chymostatin; Sigma) or
TN buffer (as TNT but without Triton X-100). Unspecific binding was
blocked by incubation with 1 µg of normal rabbit IgG (Santa Cruz
Biotechnology) and 25 µl of 6% protein A-agarose (Roche Molecular
Biochemicals) for 30 min at 4 °C followed by immunoprecipitation for
2 h at 4 °C with 1 µg of anti-kinase antibody (Santa Cruz
Biotechnology) and 25 µl of 6% protein A-agarose. After washing
three times with TNT/TN buffer as appropriate and three times with
kinase buffer (20 mM HEPES, pH 8.0; 10 mM
MgCl2; 100 µM Na3VO4;
20 mM
-glycerophosphate; 50 mM NaCl; 2 mM dithiothreitol; 0.5 µM
4-(2-aminoethyl)-benzenesulfonyl fluoride; and 0.75 µg/ml each
leupeptin, antipain, aprotinin, pepstatin A, and chymostatin), the
precipitated proteins were either analyzed by Western blot or kinase assay.
Kinase Assay--
IP was carried out as described above and
followed by the kinase assay (35, 43). The kinase reaction was
performed in kinase buffer for 30 min at 30 °C in the presence of 5 µCi of [
-32P]ATP (NEN Life Science Products) and 500 ng of the substrate GST-I
B-
(Santa Cruz Biotechnology). Proteins
were analyzed on 12.5% polyacrylamide gels (0.1% SDS), dried, and
visualized by autoradiography.
Transfection of THP-1 Cells--
The following reporter plasmids
were utilized in transfection studies: 3x
B.luci, a firefly
luciferase reporter plasmid containing three copies of a prototypic
(5'-GGGACTTTCC-3')
B site (42); TNFkop.luci, comprising 1108 base
pairs of the TNF promoter region (42); and pGL2-IL-8, containing 420 base pairs of the IL-8 promoter region (44). Overexpression plasmids
used in our studies included IKK-
, IKK-
, NIK (wild type and
mutated forms), IKAP (all gifts from Tularik Inc., South San Francisco,
CA), NEMO, I
B-
(wild type and mutated), I
B-
(gifts from
Prof. Alain Israël and co-workers, Institut Pasteur), and
antisense IKK-
(a gift from Prof. Michael Karin, University of
California-San Diego, La Jolla, CA). RcCMV (Invitrogen, Groningen,
Netherlands) containing no insert was used as a negative control in the
overexpression experiments. These plasmids, either alone or in
combination, were transiently co-transfected with a constitutively
active Renilla luciferase control plasmid, pRLtk (Promega,
Mannheim, Germany), into THP-1 cells using a DEAE-dextran-based
protocol (13, 44). After transfection, cells were plated out at a
density of 2 × 106 cells/3 ml of RPMI medium with 7%
fetal calf serum in a six-well plate and incubated for 2 days. After
this time, the cells were stimulated for 5 h with either TNF or
LPS. Subsequent to stimulation, the cells were lysed, and the
luciferase activity was determined using the dual luciferase reporter
assay system (Promega). The results are expressed as firefly luciferase
relative light units divided by the values in relative light units
obtained for the Renilla luciferase.
Pulse-Chase--
Pulse-chase experiments were carried out as
described (40). Briefly, THP-1 cells were washed in complete medium
(RPMI 1640 medium) without Met/Cys (BioWhittaker) and resuspended in
this medium at a density of 3 × 106 cells/ml. After
incubation in a 12.5-cm2 culture flask at 37 °C and 5%
CO2 for 30 min, 100 µCi of [35S]Met/Cys
(NEN Life Science Products) was added, followed by a labeling time of
3 h. The cells were then washed in the above-mentioned medium plus
500 µM Met/Cys (Boehringer Ingelheim, Ingelheim,
Germany), resuspended in this medium, and plated out at a density of
3 × 106cells/well in a 12-well plate. The plate was
returned to the incubator, and extracts were made at various times
later. Cytosolic and nuclear extracts were prepared as described (42),
except that the nuclei were incubated in Buffer B (0.02 M
HEPES, pH 7.0, 0.1 M KCl, 0.1 M NaCl, 5 mM dithiothreitol, 5 mM phenylmethylsulfonyl
fluoride, 20% glycerol, and 0.75 µg/ml each leupeptin, antipain,
aprotinin, pepstatin A, chymostatin, Sigma) plus 0.5% Nonidet P-40 for
30 min on ice prior to disruption by drawing through a narrow pipette tip. Trichloroacetic acid-precipitated proteins were assayed for cpm.
IP of equal volumes of protein was carried out using an anti-IKK-
or
-
antibody, and the resulting protein precipitate was separated by
SDS-polyacrylamide gel electrophoresis. Autoradiographs of the
vacuum-dried gels were analyzed densitometrically, the values were
corrected for the cpm loaded, and the half-life was calculated for each protein.
 |
RESULTS |
Differential Activation of IKK-
and -
--
Initial
experiments were performed to assess potential selective effects of LPS
and TNF on endogenous kinase-active signalsome subunits in human
monocytic cells. Kinase assays were carried out to monitor the activity
of IKK-
and -
following incubation with these stimuli. Cytosolic
extracts from THP-1 cells were subjected to IP with an anti-kinase
antibody and the ability of the precipitated proteins to phosphorylate
GST-I
B-
in vitro was analyzed. It should be mentioned
that 1% Triton X-100, present in the TNT buffer used for IP, disrupts
the integrity of the signalsome complex (data not shown; see also Fig.
3), allowing us to distinguish between IKK-
and -
activity.
TNF stimulation (1.6 ng/ml) elicited a rapid but rather short-lived
effect, with a maximum response from both IKK-
and -
at 5 min of
incubation (Fig. 1A), although
the IKK-
activity was greater than that of IKK-
. TNF-induced
IKK-
activity then decreased sharply after 20 min and had reached
near base-line levels by 75 min. A similar pattern was observed for
IKK-
(Fig. 1A and data not shown).

View larger version (20K):
[in this window]
[in a new window]
|
Fig. 1.
Differential activation of endogenous
IKK- and - by TNF and
LPS in monocytic cells. A, cytosolic extracts from
THP-1 cells incubated with TNF (1.6 ng/ml) were subjected to IP using
TNT buffer with either IKK- or - antibodies as indicated. A
kinase assay was performed using the substrate GST-I B- , and the
proteins were separated by SDS-polyacrylamide gel electrophoresis.
32P-Phosphorylated (circled P) GST-I B- is
shown by the arrow. B, THP-1 cells were incubated
with LPS (1 µg/ml) for the times indicated, and IP followed by kinase
assay for IKK- and - activity was performed as in A.
C, comparison between LPS- and TNF-induced IKK activity.
Experiments were performed as described in A and
B, and the peak activities (TNF, 5 min;
LPS, 30 min) were analyzed. Representative films were
scanned and quantified densitometrically. Induction above base line was
calculated, and the results are depicted. D, kinase assays
were performed as described in B, and the two peak
activities of IKK after LPS stimulus (30 and 75 min) were analyzed as
in C.
|
|
On the other hand, LPS stimulation (1 µg/ml) had a major effect on
IKK-
activity, which slowly increased and peaked at 30 min (Fig.
1B), whereas an almost negligible increase in the activity of IKK-
was observed at this time point. We also detected a second peak of IKK activity, comprising both IKK-
and -
activation, following LPS stimulation at 75 min (Fig. 1B and see below).
The peak IKK activities induced by TNF (at 5 min) or LPS (at 30 and 75 min) were analyzed by densitometry and compared. In general, the
activation of IKK by TNF was much more pronounced than that mediated by
LPS at the time points of peak activation (Fig. 1C). The
effect of TNF on IKK-
was 3-fold greater than that on IKK-
at 5 min of incubation, whereas LPS almost exclusively activated IKK-
after a 30-min stimulation period (Fig. 1, C and D). However, at 75 min of incubation, LPS appeared to induce
both IKK-
and -
activity, to approximately the same extent (Fig. 1D).
Stimulus-induced IKK-
and -
Activity ex Vivo in Human
Monocytes--
Kinase assays were also performed with cytosolic
extracts from human adherent monocytes following either TNF (1.6 ng/ml)
or LPS (100 ng/ml) stimulation. The experiments showed that TNF rapidly induced IKK activity (IKK-
> IKK-
) with an early peak at 5 min (Fig. 2A). Similar to the
effect seen in THP-1 cells, LPS exposure led to a slow increase
in predominantly IKK-
activity with a peak at 30 min (Fig.
2B).

View larger version (25K):
[in this window]
[in a new window]
|
Fig. 2.
Activation of IKK ex vivo in
human monocytes. Adherent human monocytes were stimulated with TNF
(1.6 ng/ml) (A) or LPS (100 ng/ml) (B) for the
times indicated. IP of cytosolic extracts with either IKK- or -
antibodies in TNT buffer was carried out as shown, and kinase assays
with GST-I B- as substrate were performed as in Fig. 1.
32P-Phosphorylated GST-I B- (circled P) is
shown by the arrows.
|
|
The Role of NIK in I
B Phosphorylation--
Next, we tested
whether monocytic endogenous NIK, another kinase-active signalsome
component, can itself directly phosphorylate I
B-
substrate. For
this purpose, IP with an antibody raised against NIK was performed
under different conditions. As already mentioned, the presence or
absence of Triton X-100 in the IP buffer is important with respect to
the integrity of the precipitated complex. TN buffer (without
detergent) or TNT buffer (1% Triton X-100) was used in the IP step
following LPS or TNF stimulation of THP-1 cells. The subsequent kinase
assay showed that in the absence of detergent, a strong kinase activity
following LPS stimulation was detected (Fig.
3, TN). However, when
detergent was present and the precipitated protein was almost
exclusively NIK alone (data not shown), no phosphorylation of the
substrate was observed (Fig. 3, TNT). A similar result was
seen when TNF was used as the stimulus (Fig. 3). It should be noted
that in some experiments, the peak activity following exposure to TNF
was observed at an earlier time point than 5 min. The results suggest
that in monocytic cells, NIK itself cannot phosphorylate the substrate
I
B-
. The activity seen in the absence of Triton X-100 must be due
to kinases that have co-precipitated with NIK in the signalsome
complex.

View larger version (27K):
[in this window]
[in a new window]
|
Fig. 3.
NIK does not directly phosphorylate
I B- in monocytic
cells. Cytosolic extracts from LPS- or TNF-stimulated THP-1 cells
were immunoprecipitated with anti-NIK antibody in the presence
(TNT) or absence (TN) of the detergent Triton
X-100. Kinase assays were carried out as described in Fig. 1.
Circled P, phosphorylated form.
|
|
Level of the Signalsome Components in Monocytic Cells--
Before
further analysis of the signalsome complex (see below), we wanted to
establish the presence and level of endogenous I
B kinase-active
components and associated subunits of the signalsome in monocytic
cells. An additional aim was to examine whether the endogenous
concentration of these molecules is changed following incubation with
potent monocyte activators, such as LPS and TNF. For this purpose,
THP-1 monocytic cells were incubated with LPS or TNF, and the level of
IKK-
, -
, and -
(NEMO), as well as of NIK, was determined by
Western blot analysis.
In unstimulated monocytic cells, we detected a significant endogenous
level of all the above-mentioned signaling proteins (IKK-
, IKK-
,
NIK, and IKK-
), as shown in Fig. 4.
Following treatment with LPS or TNF, the levels of IKK-
and IKK-
(Fig. 4A and data not shown), as well as NIK and IKK-
(Fig. 4B and data not shown), were not significantly
altered, suggesting a tight regulation of these components in
monocytes. As a control, the concentration of
-actin was also
monitored; its level was not influenced by any of the incubation
conditions used (Fig. 4A).

View larger version (46K):
[in this window]
[in a new window]
|
Fig. 4.
Level of endogenous signalsome components in
monocytic cells. THP-1 cells were treated with LPS, and cytosolic
extracts were examined by Western blot for the presence of IKK- and
- (A) or NIK and IKK- (B) proteins.
-Actin levels were assayed as a loading control; in A, a
representative blot for the experiment is shown.
|
|
Northern blotting for the mRNA coding for IKK-
and -
revealed
only a weak signal in both stimulated and unstimulated cells (data not
shown). Because this low level of mRNA contrasts with the
relatively high constitutive expression of the proteins in this system,
we decided to investigate the half-lives of these kinases by
pulse-chase analysis. Using this technique the half-life of endogenous
IKK-
and -
was found to be 12.8 ± 0.1 h
(n = 2) and 12.7 ± 0.1 h (n = 2), respectively, which indicates a relatively high stability of both
signaling molecules in monocytic cells.
Analysis of the Signalsome Complex--
The association of the
endogenous kinase-active signalsome components (IKK-
, IKK-
, and
NIK) and the inhibitor proteins I
B-
and -
was investigated in
monocytic cells under various conditions. Initially, IP using a
monoclonal antibody raised against IKK-
was performed on cytosolic
extracts, followed by Western blot analysis of the co-precipitated
proteins. In the absence of detergent in the IP buffer, we saw the
complex components IKK-
and NIK, as well as bound I
B-
and
-
, co-precipitated by the anti-IKK-
antibody from unstimulated
cell extracts (Fig. 5 and data not shown), whereas in the presence of Triton X-100, only the directly precipitated protein was observed (data not shown). This demonstrated the occurrence of IKK-
/
heterodimers in monocytic cells and showed that these subunits are already associated with NIK as well as
I
B-
and -
in unstimulated cells. The complex precipitated in
the absence of detergent, as far as we were able to ascertain, did not
alter in IKK-
, IKK-
, or NIK composition throughout treatment with
LPS or TNF (Fig. 5 and data not shown). A different pattern was
observed for I
B-
, which, following LPS stimulation, slowly disappeared from the complex over 60 min, being undetectable at this
time, and then gradually reassociated (Fig. 5A). This agrees with the phosphorylation and proteolysis pattern that we observed in
parallel studies (Fig. 5A). In contrast, TNF stimulation led to a clear phosphorylation of I
B-
after 1 min of incubation (Fig.
5B). This phosphorylated form remained bound to the complex until 5 min, at which time it disappeared. The inhibitor protein then
reassembled with the signalsome complex by 45 min, in its unphosphorylated form. The other inhibitory protein, I
B-
, was also initially associated with the signalsome complex and, after TNF
stimulation, gradually disappeared. It was not found to reassociate, which is presumably due to the limited time frame studied here (see
also Fig. 8).

View larger version (37K):
[in this window]
[in a new window]
|
Fig. 5.
Composition of the monocytic signalsome
complex following activation. THP-1 cells were incubated with LPS
(A) or TNF (B) for the times indicated.
IP+WB, Cytosolic extracts were prepared, and IP in TN buffer
with anti-IKK- was carried out. The precipitated proteins were then
analyzed by Western blot for the presence of the signalsome components
IKK- and - , as well as I B- and - . The double
arrowhead for I B- in B indicates the
phosphorylated (upper) and unphosphorylated
(lower) form. WB, in parallel experiments,
cytosolic extracts were examined by Western blot for the presence of
I B- . In some cases, an antibody that exclusively recognizes this
protein in its stimulus-induced phosphorylated form (circled
P) was applied.
|
|
Overexpression of Wild Type or Mutated Kinase-active Signalsome
Components--
Next, we examined the effect of the kinase-active
proteins IKK-
and -
, as well as NIK, on LPS- and TNF-induced
B-dependent transcription. We transfected THP-1 cells
with overexpression vectors for both wild type and mutated kinases
together with luciferase reporter plasmids.
Initially, transfection efficiency was assessed by Western blotting of
cytosolic extracts from kinase-transfected THP-1 cells, using an
antibody raised against the Flag tag present on the overexpressed proteins. This confirmed that the protein was being overexpressed at
equal levels in our system and that the control vector without a tagged
overexpression protein showed no signal (data not shown).
The effect of both wild type and mutated IKK-
, -
, and NIK was
investigated using TNF and LPS as stimuli and 3x
B.luci as a reporter
plasmid. The mutated, kinase-inactive proteins were all able to reduce
LPS- or TNF-induced
B-dependent transcription below the
level seen with the wild type proteins, with an effectiveness of
IKK-
< IKK-
< NIK (Fig.
6A). NIK wild type alone, in
the absence of a stimulus, was also capable of causing an increase in
B-dependent transcription (4.7-fold over the base-line
level of transcription observed in the presence of mutated,
kinase-inactive NIK). Neither wild type IKK-
nor -
was able to
affect transcription in the absence of a stimulus. In addition,
antisense IKK-
, when overexpressed in THP-1 cells, was able to
inhibit LPS-induced
B-dependent, as well as TNF
promoter-dependent, transcription (data not shown), in
contrast to the sense (i.e. wild type IKK-
). The control
vector RcCMV, which contains no inserted DNA, had no effect on
transcription.

View larger version (26K):
[in this window]
[in a new window]
|
Fig. 6.
Overexpression of wild type and mutated
kinase-active signalsome components. THP-1 cells were transiently
transfected with overexpression plasmids for either wild type or
mutated kinase-active signalsome components, together with 3x B.luci
and a Renilla luciferase constitutively expressed control
plasmid. A 5-h stimulation with either LPS or TNF was followed by
luciferase measurement using the dual luciferase reporter assay kit.
Results are expressed as firefly relative light units divided by
Renilla relative light units. A, wild type
(wt) or mutated (mut.) IKK- , IKK- , or NIK
was transfected into cells that were stimulated as shown. B,
double transfection experiments with co-transfection of two kinase
elements were performed, and the cells were stimulated as indicated.
C, triple transfection experiments were carried out, with
all three kinases transfected together into the cells, in the
combinations indicated. RLA, relative luciferase activity;
Con, control, unstimulated cells.
|
|
Double transfections, in which either wild type or mutated IKK-
and
-
were transfected together into THP-1 cells, showed an increase in
the effectiveness of the mutated kinases in inhibition of the LPS- and
TNF-induced
B-dependent transcription (Fig.
6B).
Triple transfections, with all three kinases transfected at the same
time into cells, showed that an inhibition of the LPS stimulus of 60%
was achieved when all kinases were mutated and inactive (Fig.
6C). Mutation of just one of the kinases led to a partial
inhibition of the stimulus, with inactive IKK-
having the weakest
effect and mutated NIK having an effect almost as strong as that seen
when all three kinases were inactive.
Transfection of Nonkinase Members of the Signalsome
Complex--
To obtain some insight into possible functional aspects
of the scaffold proteins IKAP and IKK-
(NEMO), transfection
experiments were carried out. Interestingly, overexpression of IKAP or
NEMO in THP-1 cells resulted in two contrasting effects. IKAP
overexpression led to a partial inhibition of both LPS- and TNF-induced
B-dependent transcription, seen with either 3x
B.luci
or IL-8 and TNF promoter-dependent constructs (Fig.
7A and data not shown). Both
LPS- and TNF-induced 3x
B.luci or IL-8 promoter-dependent
transcription were inhibited by approximately 50%. IKAP alone
influenced
B-dependent transcription to a certain
degree, leading to an increase of 2.2-fold above base-line. NEMO,
however, caused a slight rise (1.6-fold) in the level of
B-dependent transcription, over and above the effect seen with LPS and TNF alone (Fig. 7B). In the absence of
external stimuli, NEMO-transfected cells also showed a small increase
(1.8-fold) in transcriptional activity over the base-line levels.

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 7.
Overexpression of kinase-inactive subunits of
the signalsome. THP-1 cells were transfected with a luciferase
reporter plasmid (either 3x B.luci or the IL-8
promoter-dependent construct as indicated), together with
the Renilla control plasmid and IKAP (A) or NEMO
(B) overexpression vector. The cells were either stimulated
for 5 h with LPS (L) or TNF (T) or left
untreated (C) and assayed as in Fig. 6. CMV
indicates the empty overexpression vector RcCMV, used as a
control.
|
|
I
B Proteolysis and Overexpression of I
B-
and -
--
To
investigate whether the differential activities of IKK after LPS or TNF
stimulation affect the proteolysis and resynthesis of the recently
cloned I
B-
, as well as I
B-
, we studied the kinetics of
I
B degradation and subsequent resynthesis following either LPS or
TNF stimulation. Maximal degradation of I
B-
occurs relatively
late following LPS exposure, after a 90-min stimulus (Fig.
8A). This inhibitory protein
was rapidly resynthesized, reaching base-line expression levels by 120 min of incubation. A similar degradation pattern was found for
I
B-
after LPS challenge, but in contrast to I
B-
, this was
not followed by resynthesis of the I
B-
protein, at least within
the time frame studied here (Fig. 8A). I
B-
was
degraded much more rapidly by incubation with TNF, with an almost
complete degradation achieved by 10 min (Fig. 8B), followed
by a relatively long lag phase and thereafter resynthesis of the
protein by 75 min. I
B-
also quickly underwent proteolysis after
TNF stimulation, with no significant resynthesis up to 120 min
later (Fig. 8B).

View larger version (22K):
[in this window]
[in a new window]
|
Fig. 8.
I B proteolysis and
overexpression of I B- and - . A, cytosolic
extracts from THP-1 cells treated with LPS were examined by Western
blot analysis for the presence of I B proteins as shown.
B, the presence of these proteins was also investigated
following TNF stimulation. C, wild type or mutated I B-
overexpression plasmids were transfected into THP-1 cells, and the
effect on B-dependent, as well as IL-8
promoter-dependent, transcription following incubation with
LPS (L), TNF (T) or in the absence of stimulus
(C) was analyzed as described in Fig. 6. D, the
effect of overexpression of I B- was assayed as described in
C. CMV represents the empty RcCMV overexpression
plasmid, used as a control.
|
|
We also examined the effect of overexpression of the inhibitory
proteins I
B-
and -
in THP-1 cells to investigate whether these
proteins are involved in shutdown of NF-
B activity. A contrasting result was seen between the two proteins. Transfection of an I
B-
wild type vector led to a reduction in stimulus intensity of
B-dependent transcription following incubation with LPS
or TNF (Fig. 8C). The mutated form of I
B-
, which
cannot be phosphorylated, also caused inhibition of the above-mentioned
stimulus-induced transcription and was in fact even more effective than
the wild type molecule (Fig. 8C). Both 3x
B.luci and IL-8
promoter-dependent transcription was similarly affected. In
contrast, I
B-
overexpression led to a reinforcement, rather than
an inhibition, of the LPS- and TNF-induced stimulation for all the
plasmids examined (Fig. 8D). The signal intensity was more
markedly increased (3-fold) in 3x
B.luci-transfected than in IL-8
promoter construct-transfected cells. I
B-
overexpression alone,
in the absence of external stimuli, led to a marginal rise in the level
of transcription, more clearly visible in IL-8 promoter construct-transfected cells than in those transfected with
3x
B.luci.
 |
DISCUSSION |
Both LPS and TNF belong to the most potent activators of NF-
B
in cells of the monocytic lineage (5, 6, 14). However, the signaling
cascades leading to NF-
B activation induced by these stimuli appear
to differ markedly (24, 26, 43). The present paper elucidates the
effects of LPS, as well as TNF, on endogenous monocytic IKK signalsome
activation and subsequent phosphorylation/proteolysis of the I
B
inhibitory proteins. Our study reveals that a completely different
signalsome activation pattern results from incubation of cells with
these two highly effective stimulating molecules.
Incubation of human monocytic cells with LPS predominantly activated
IKK-
in our kinase experiments using I
B-
as a substrate with a
slow increase leading to a peak of activation at 30 min. At this time
point, only a negligible activation of IKK-
by LPS was observed. In
addition, a second IKK activation peak was seen at a later time point
(75 min), which consisted of both IKK-
and IKK-
activity. This
may be caused by continuous stimulation induced by the presence of LPS
in the medium and/or autocrine mechanisms. A recent report describes
the activation of IKK by LPS in THP-1 cells (but does not distinguish
between IKK-
and -
) with a maximum at 60 min (27). In these
experiments, the exclusive dominant-negative expression of IKK-
, but
not IKK-
, partially inhibited LPS-induced transcriptional activity
(27). This is in contrast to our study, as well as recently published results (26), in which the expression of both dominant-negative IKK-
and IKK-
exerted inhibitory effects. The differences between these
studies (peak of activation and effect of dominant-negative IKK-
)
could be due to differences in THP-1 sublines/cell types (13). When
these data are taken together, our study indicates that IKK-
is the
major target of LPS signaling but also suggests a modest activation of
IKK-
, especially at a later time point.
In contrast, TNF preferentially activated IKK-
with a dramatic, very
early peak of activation at 5 min. Furthermore, a significant effect of
TNF on IKK-
activity was observed that was approximately 3-fold
lower than that on IKK-
but showed a similar time course of
activation. No second peak at a later time point was observed in the
presence of TNF. A TNF-induced early peak of IKK activity was also
observed in HeLa cells, when the whole signalsome complex was isolated
and used for kinase assays, as well as in IKK-
and IKK-
overexpression studies (28, 29, 32). In the latter experiments, equal
effects of TNF and IL-1 on IKK-
and IKK-
were observed (28),
which contrasts with our TNF studies and may potentially be due to the
fact that the functionality of overexpressed proteins does not
precisely mirror the endogenous situation.
Our studies suggest that endogenous NIK, another kinase-active
signalsome component (30, 31), is not able to directly phosphorylate
I
B-
following LPS or TNF exposure of monocytic cells.
Nevertheless, transfection studies indicate that NIK may be a
functionally important subunit of the complex because dominant-negative expression of NIK appeared to be even slightly more effective than that
of IKK-
or IKK-
in inhibiting LPS-induced, as well as
TNF-induced,
B-dependent transcriptional activity. This
may result from the more upstream orientation of NIK imposing a tight negative regulation over IKK (37). Recent overexpression studies in 293 cells demonstrate the association of NIK with IKK-
and, to a lesser
extent, with IKK-
(31) and the specific phosphorylation of Ser-176
of IKK-
by the NIK molecule (45).
In unstimulated monocytic cells, the endogenous signalsome contained
IKK-
/IKK-
heterodimers that appeared to be associated with NIK,
I
B-
, I
B-
, and presumably additional proteins not examined
in this study (see also Ref. 37). Recently, it has been concluded from
transfection experiments that heterodimers represent the most active
IKK kinase subconfiguration (31). Following stimulation with LPS/TNF,
the IKK proteins, as well as NIK, remained in the complex, whereas
I
B-
disappeared and at a later time point reassociated, a finding
completely consistent with the stimulus-specific patterns of I
B
proteolysis and resynthesis observed in parallel experiments. A similar
stimulus-induced release from the signalsome multimolecule was found
for I
B-
. Interestingly, a recent study suggested that
overexpressed IKK-
associates with I
B-
bound to p65-p50, and
it was proposed that phosphorylation induces the release of the
inhibitor protein (30). A reverse approach demonstrated that mutations
of Ser-32 and Ser-36 of I
B-
(preventing phosphorylation)
increased the signalsome association of the I
B protein (31). At the
structural level, it has been suggested that the kinase and leucine
zipper domains of IKK-
may be required for interaction with
I
B-
(31). This association pattern could also imply fine-tuned
direct interactions between the high molecular weight complex
signalsome, responsible for phosphorylation (28-32), and the
proteasome, representing the degrading machinery (21, 22).
Another as yet unanswered question concerns the role of the
kinase-inactive adaptor/scaffold proteins IKAP (37) and IKK-
(NEMO
and IKK associated protein 1) (34-36) in signalsome-mediated signal
transduction. In our studies, overexpression of IKAP in monocytic cells
partially reduced LPS-stimulated, as well as TNF-stimulated, transcriptional activity. In 293 cells, an increased level of IKAP has
been shown to inhibit TNF- and IL-1-induced
B-dependent transcription, and it was suggested that it may inhibit cytokine signaling by titrating out each individual component of the IKK signalsome (37), e.g. a higher level of IKAP may compete
with kinase-active molecules. In contrast, the presence of exogenous NEMO enhanced both LPS- and TNF-induced transcription in our
experiments. Recently, it has been shown that IKK associated protein 1 preferentially interacts with IKK-
(36), and it has been suggested
that this protein provides a scaffold upon which IKK-
-containing
complexes could be localized to the upstream components of the NF-
B
activation cascade (34-36). Alternatively, a higher level of IKK-
in the signalsome may lead to an increased recruitment of the I
B
substrate or proteasome particles, which could also be a reason for the observed enhancement.
One technical issue should be discussed, and that is the reliability of
transfection/overexpression studies. In our experiments, dominant-negative expression of IKK-
, IKK-
, or NIK in monocytic THP-1 cells led only to a partial inhibition of both LPS- and TNF-activated
B-dependent transcription, with triple
transfection most effective, in contrast to earlier studies using HeLa
or 293 cells demonstrating a much more profound effect (26, 28, 31, 45). In addition, using the transfection strategies, we were not able
to confirm the LPS- or TNF-induced differential pattern of IKK-
and
IKK-
activation seen in our kinase assays, which we consider a more
clean and direct approach. Furthermore, we were not successful in
establishing a direct effect of wild type IKK-
and IKK-
on
B-regulated transcriptional activity observed under the cell culture
and overexpression conditions already mentioned (28, 31). One reason
for these discrepancies may be a technical problem, which is the low
transfection efficiency using monocytic cells. Another reason could be
that overexpression of proteins may create unphysiological conditions
(46). For example, exogenously added IKK may form nonphysiological
dimers/complexes, which may display lower or dysregulated kinase
activities (31, 47). Therefore, endogenous IKK-
/
heterodimers
could overcome at least partially the effect of the specifically
overexpressed proteins in monocytic cells and bias our results such
that we did not achieve a clear cut kinase activation pattern.
When these data are taken together, LPS appears to only modestly but
preferentially stimulate IKK-
activity over a longer time interval,
whereas the effect of TNF on the IKK kinase-active molecules
(IKK-
> IKK-
) is marked and rapid but appears to be rather
limited. Because the effect of LPS on IKK activity was much weaker than
that of TNF, one could argue that the IKK pathway represents just one
of several parallel signaling pathways induced by LPS leading to
NF-
B activation. In fact, LPS is known to initiate signal
transduction cascades resulting in a spray-like activation of a network
of kinases, G-proteins, cyclic nucleotide metabolizing enzymes, lipid
second messengers, and ion channels, some of which even may be not
related to NF-
B (2). Furthermore, additional kinases may be involved
in LPS-mediated I
B phosphorylation (39, 48, 49). On the other hand,
a modest but continuous activation of IKK by LPS may prove essentially
as effective as the rapid but short-lived activation of IKK seen
following TNF challenge of cells. In this context, it should be noted
that LPS or TNF led to a different proteolysis pattern of I
B-
,
-
, and -
in our work, which incidentally completely agreed with
the IKK activation pattern, but finally led under both activation
conditions to a marked removal of the inhibitory proteins.
One important issue that has to be addressed in the future is the
question of why LPS induces slow motion signaling, whereas TNF
activates a rapid motion pathway, and what signaling molecules are
involved. In any case, the differential IKK activation pattern following LPS or TNF stimulation may provide therapeutical avenues: for
example, the specific inhibition of IKK-
would block LPS effects
responsible for numerous deleterious effects in the organism but only
partially inhibit TNF to a level potentially still required and
sufficient for proper immune responses. Therefore, a deeper molecular
understanding of how LPS and TNF affect cellular pathways may allow new
approaches to improve the fatal outcome of the sepsis-associated wasting disease.
 |
ACKNOWLEDGEMENTS |
We thank Dr. Mike Rothe (Tularik Inc.)
(IKK-
, -
, and NIK), Prof. Patrick A. Baeuerle (Tularik Inc.)
(IKAP), and Prof. Michael Karin (AS-IKK-
) for the generous gifts of
the overexpression plasmids, as well as Prof. Alain Israël and
co-workers for the gifts of I
B-
and I
B-
overexpression
plasmids and the NEMO antibody. The luciferase reporter plasmids
3x
B.luci and the TNF promoter-dependent construct were
from Prof. H. W. Löms Ziegler-Heitbrock, and the IL-8
promoter construct was from Prof. Nigel Mackman, to whom we are very
grateful. We also thank Prof. Nancy Rice for the kind gift of I
B-
antibody. We also thank Drs. Monika Haas and Michael Page for valuable
contributions and interesting discussions, as well as Nadja Kern for
excellent technical assistance.
 |
FOOTNOTES |
*
This work was supported by Grants SFB 469 and Br 1026/3-2
from the Deutsche Forschungsgemeinschaft and Grant H 50-98 from the
Medical Faculty of the Technical University of Munich.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
The first two authors contributed equally to this work.
§
To whom correspondence should be addressed. Tel.: 49-89-4140-4084;
Fax: 49-89-4140-4875.
 |
ABBREVIATIONS |
The abbreviations used are:
LPS, lipopolysaccharide;
TNF, tumor necrosis factor;
IL, interleukin;
IKK, I
B kinase;
NIK, NF-
B-inducing kinase;
NEMO, NF-
B essential
modulator;
IKAP, IKK complex-associated protein;
IP, immunoprecipitation;
GST, glutathione S-transferase;
CMV, cytomegalovirus.
 |
REFERENCES |
| 1.
|
Parillo, J. E.
(1993)
N. Eng. J. Med.
328,
1471-1477[Free Full Text]
|
| 2.
|
Sweet, M. J.,
and Hume, D. A.
(1996)
J. Leukocyte Biol.
60,
8-26[Abstract]
|
| 3.
|
Ulevitch, R. J.,
and Tobias, P. S.
(1995)
Annu. Rev. Immunol.
13,
437-457[CrossRef][Medline]
[Order article via Infotrieve]
|
| 4.
|
Bazzoni, F.,
and Beutler, B.
(1996)
N. Eng. J. Med.
334,
1717-1725[Free Full Text]
|
| 5.
|
Siebenlist, U.,
Franzoso, G.,
and Brown, K.
(1994)
Annu. Rev. Cell Biol.
10,
405-455[CrossRef]
|
| 6.
|
Müller, J. M.,
Ziegler-Heitbrock, H. W. L.,
and Baeuerle, P. A.
(1993)
Immunobiol.
187,
233-256[Medline]
[Order article via Infotrieve]
|
| 7.
|
Brand, K.,
Page, S.,
Rogler, G.,
Bartsch, A.,
Brandl, R.,
Knuechel, R.,
Page, M.,
Kaltschmidt, C.,
Baeuerle, P. A.,
and Neumeier, D.
(1996)
J. Clin. Invest.
97,
1715-1722[Medline]
[Order article via Infotrieve]
|
| 8.
|
Baeuerle, P. A.,
and Baichwal, V. R.
(1996)
Adv. Immunol.
65,
111-137
|
| 9.
|
Barnes, P. J.,
and Karin, M.
(1997)
N. Eng. J. Med.
336,
1066-1071[Free Full Text]
|
| 10.
|
Böhrer, H.,
Qiu, F.,
Zimmermann, T.,
Zhang, Y.,
Jllmer, T.,
Männel, D.,
Böttinger, B. W.,
Stern, D. M.,
Waldherr, R.,
Saeger, H.-D.,
Ziegler, R.,
Bierhaus, A.,
Martin, E.,
and Nawroth, P. P.
(1997)
J. Clin. Invest.
100,
972-985[Medline]
[Order article via Infotrieve]
|
| 11.
|
Rogler, G.,
Brand, K.,
Vogl, D.,
Page, S.,
Hofmeister, R.,
Andus, T.,
Knuechel, R.,
Baeuerle, P. A.,
Schölmerich, J.,
and Gross, V.
(1998)
Gastroenterology
115,
357-369[CrossRef][Medline]
[Order article via Infotrieve]
|
| 12.
|
Brand, K.,
Fowler, B. J.,
Edgington, T. S.,
and Mackman, N.
(1991)
Mol. Cell. Biol.
11,
4732-4738[Abstract/Free Full Text]
|
| 13.
|
Mackman, N.,
Brand, K.,
and Edgington, T. S.
(1991)
J. Exp. Med.
174,
1517-1526[Abstract/Free Full Text]
|
| 14.
|
Grilli, M.,
Chiu, J. J.-S.,
and Lenardo, M. J.
(1993)
Int. Rev. Cytol.
143,
1-62[Medline]
[Order article via Infotrieve]
|
| 15.
|
Baldwin, A. S.
(1996)
Annu. Rev. Immunol.
14,
649-681[CrossRef][Medline]
|